Service · Georgia

Cross-border settlement for nutraceutical and supplement brands with a Georgian company

Yes, Georgian companies in the nutraceutical and supplement sector can secure cross-border settlement accounts with international and European payment institutions. Success depends on demonstrating clear economic substance, providing a legitimate rationale for all fund flows, and satisfying provider concerns about health claims and billing models. We prepare a complete file that maps your group structure and documents your intercompany settlement needs, then introduce you to appropriate regulated providers.

Profile at a glance
Service
Cross-border settlement
Industry
Nutraceutical and supplement
Typical MCC
5499
Entity
Limited liability company (LLC), optionally with International or Virtual Zone status
Authorities
National Agency of Public Registry; National Bank of Georgia, including for VASPs
Currencies
GEL, USD, EUR
Prerequisite
Product registration or notification where required
Reserves
Common; indicative
Timeline
Typically 3 to 8 weeks across both ends of a corridor

How we arrange cross-border settlement for Georgian nutraceutical companies

We begin by mapping your corporate structure and the settlement corridors you require, whether for repatriating profits, paying overseas suppliers, or moving funds between related entities. For a Georgian nutraceutical business, this often involves corridors between Georgia, the EU, and the US. We identify the most suitable types of regulated partners for each leg of the journey, such as EEA-licensed payment institutions for EUR settlements or international banks for USD transfers.

Our process focuses on making your case clear and compelling to the provider. We review your intercompany agreements, transfer justifications, and compliance documents to ensure they are ready for institutional scrutiny. This involves checking that your product claims are compliant, your billing models are transparent, and your corporate documents are in order. By presenting a bank-ready file, we introduce you to providers on both sides of each required corridor, streamlining the process and reducing friction. After onboarding, we help monitor your transaction flows to pre-empt compliance reviews that could otherwise freeze your settlement capabilities.

What underwriters check for Georgian nutraceutical businesses

Compliance teams at prospective payment providers will scrutinise several key areas for a Georgian-domiciled nutraceutical company. They first need to understand your corporate structure and the ultimate beneficial owners, so a clear group chart is essential. Underwriters will then analyse the intercompany agreements that justify the fund flows, wanting to see a clear commercial rationale for why money is moving between specific jurisdictions.

For the nutraceutical industry, they will assess product risk. This involves reviewing marketing materials to ensure no prohibited health or disease-cure claims are made. They will examine your billing practices, paying close attention to continuity or subscription models to ensure they are transparent and fair to consumers, mitigating the risk of high chargebacks. We ensure your file includes product ingredient lists, any required product registrations, and clear examples of your checkout and cancellation process. The goal is to demonstrate that the business is legitimate, compliant, and operates with transparency, addressing the specific risk drivers associated with the nutraceutical sector head-on.

How we run it

  1. 1.Group structure and intercompany flows mapped
  2. 2.Settlement corridors and institution types matched
  3. 3.Intercompany agreements and flow documentation checked for bank readiness
  4. 4.Accounts introduced on both sides of each corridor
  5. 5.Ongoing flows monitored so reviews do not freeze settlement

Documents to prepare

  • Registry extract
  • Charter
  • Local address confirmation
  • Product ingredient lists
  • Billing and cancellation flow
  • Marketing samples
  • Passport and proof of address for each UBO and director

How a Georgian entity choice impacts settlement strategy

Using a Georgian LLC for your nutraceutical business presents specific opportunities and challenges for cross-border settlement. The jurisdiction allows for company registration in a matter of days and permits foreign ownership, making it an accessible corporate vehicle. Accounts can hold GEL, USD, and EUR, aligning with common international settlement needs. However, while local banks are accustomed to foreign-owned companies, their appetite for international payment flows without a clear local connection is diminishing. Therefore, establishing local substance, such as a resident director or a physical office, significantly strengthens your banking relationships and the rationale for using Georgia as a base.

The National Bank of Georgia regulates financial institutions and certain virtual asset service providers, adding a layer of local oversight. For tax purposes, your Georgian LLC is subject to monthly and annual filings, with profit tax levied upon distribution. Any settlement strategy must account for these reporting obligations. We help frame your application to show providers how your Georgian setup is a legitimate part of a global operation, not an attempt to obscure ownership or liabilities.

Why nutraceutical settlement accounts are declined or closed

Settlement accounts for nutraceutical firms using a Georgian entity are often declined for reasons related to both the industry and the jurisdiction. A primary cause is a poorly explained corporate structure. If a provider cannot understand the flow of funds or the commercial purpose of the Georgian company, they will decline the application. This is particularly true if the company lacks demonstrable substance in Georgia, making the structure appear artificial. For nutraceuticals specifically, providers reject files with aggressive or unsubstantiated health claims, such as promises to cure diseases. Likewise, opaque free-trial or continuity billing models are a major red flag due to their association with high chargeback rates and consumer complaints.

Accounts can also be frozen or closed post-onboarding. This often happens when transaction patterns do not match the activity described in the application, or if chargeback ratios breach the provider’s threshold. Our approach prevents these issues by building a file that transparently details your business model, corporate structure, and settlement requirements from the outset. We document the economic purpose of your Georgian entity and ensure your marketing and billing practices can withstand underwriting scrutiny, creating a sustainable partnership with your payment providers.

Timeline, onboarding and maintaining your settlement corridors

For a Georgian nutraceutical company, establishing a robust cross-border settlement corridor typically takes between three and eight weeks. This timeframe covers the entire process for one corridor, including file preparation, introduction to institutions at both ends, and the providers’ own due diligence and onboarding procedures. The timeline can vary depending on the complexity of your group structure, the jurisdictions involved, and the specific compliance requirements of the selected financial institutions. For instance, a simple EUR settlement corridor to an EEA-licensed payment institution may be quicker to arrange than a multi-currency solution involving several international banks.

Onboarding requires a complete file containing corporate documents for the Georgian LLC, detailed information on the UBOs, and business documentation specific to nutraceuticals. Once live, maintaining the accounts is an ongoing process. We assist by helping you manage relationships with the providers and ensuring that your transaction activity remains consistent with the profile you presented. Proactive communication and regular file updates are key to preventing account reviews or freezes, ensuring your settlement capabilities remain stable as your business grows.

Georgia compared for nutraceutical and supplement brands

JurisdictionEntityCurrenciesBanking reality
GeorgiaLimited liability company (LLC), optionally with International or Virtual Zone statusGEL, USD, EURLocal banks onboard foreign founders relatively quickly, with growing scrutiny on crypto flows
MauritiusGlobal Business Company (GBC) or Authorised CompanyUSD, EUR, MURLocal banks onboard GBCs through the management company; well suited to Africa and India facing flows
US LLCLimited liability company (commonly Wyoming, Delaware or New Mexico)USD, with EUR and GBP via EMIsFintech accounts open readily for clean profiles; high-risk MCCs usually need a specialist US or international acquirer
UK LtdPrivate company limited by sharesGBP, EUR, USDStrong EMI market; high street banks are conservative with non-resident directors and high-risk sectors

General information, not legal or tax advice. Requirements change; confirm with your counsel.

What we will not do

  • Process negative-option trial scams
  • Accept disease-cure claims
  • Open accounts for unlicensed activity where a licence is required
  • Help conceal beneficial ownership or source of funds
  • Work with sanctioned persons, countries or goods
  • Promise approval: every institution makes its own decision

Xavion Capital is not a bank, acquirer or payment institution. We prepare files and introduce lawful, properly licensed businesses to regulated institutions.

Frequently asked
Do I need a local director in Georgia for a nutraceutical settlement account?
While not a strict legal requirement for company formation, having a local director or demonstrating significant management presence in Georgia substantially strengthens your application for settlement accounts. Underwriters at international payment institutions look for economic substance to justify the company's jurisdiction. A local director and physical office provide a clear signal that the Georgian LLC is a legitimate operational base, not just a shell company. This helps satisfy anti-avoidance rules and gives providers confidence in the long-term viability of your business, making them more comfortable handling your cross-border flows.
What is the MCC for a Georgian nutraceutical business?
Nutraceutical and supplement businesses are typically assigned the Merchant Category Code (MCC) 5499: Miscellaneous Food Stores. While this is the standard classification, some acquirers may use a more specific code depending on your exact business model, such as 5976 for direct-selling merchants if applicable. The MCC is important as it signals your industry to the card schemes and payment providers, who associate it with certain risk factors like chargeback probability. It is critical that your business activities align with the assigned MCC to avoid compliance issues with your payment service providers.
Can I settle crypto revenue to my Georgian company bank account?
Settling revenue from virtual asset services to a Georgian company bank account is challenging but potentially feasible with the right approach. Local banks and international providers are showing growing scrutiny towards crypto-related flows due to evolving regulations from the National Bank of Georgia. To be successful, you must demonstrate a robust AML/CFT framework, full compliance with any VASP registration requirements, and a clear, verifiable source for all funds. We can help prepare a file that documents your compliance posture and introduces you to the limited number of regulated institutions that may consider these flows.
What intercompany agreements are needed for cross-border settlement?
To justify fund movements from your Georgian nutraceutical company, you will need formal intercompany agreements. The specific type depends on the transaction. Common examples include loan agreements for financing between entities, service agreements if one company provides marketing or management services to another, and distribution agreements for the transfer of profits. These documents must be legally sound, signed, and clearly state the commercial rationale for the fund transfers. Underwriters review them to ensure that all flows are legitimate and not intended to obscure the source of funds or evade tax.
Are reserves required for nutraceutical settlement accounts?
Yes, it is common for payment providers to require a rolling reserve for nutraceutical businesses, particularly those using subscription or trial-based billing models. Reserves help the provider mitigate the financial risk from chargebacks, which can be higher in this sector. An indicative reserve might be 10% of volume held for 90 to 180 days, but the exact terms depend on your processing history, chargeback ratio, billing model transparency, and the provider's own risk policy. Presenting a file that demonstrates clear billing and easy cancellation can help negotiate more favourable reserve conditions.
Confidential assessment

Talk to us about cross-border settlement for your nutraceutical and supplement business

Send your structure, industry and volumes. A partner replies within one business day.

Replies within 1 business day · Confidential